270 related articles for article (PubMed ID: 29116202)
1. Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
Valdés-Mora F; Gould CM; Colino-Sanguino Y; Qu W; Song JZ; Taylor KM; Buske FA; Statham AL; Nair SS; Armstrong NJ; Kench JG; Lee KML; Horvath LG; Qiu M; Ilinykh A; Yeo-Teh NS; Gallego-Ortega D; Stirzaker C; Clark SJ
Nat Commun; 2017 Nov; 8(1):1346. PubMed ID: 29116202
[TBL] [Abstract][Full Text] [Related]
2. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA
Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.
Valdés-Mora F; Song JZ; Statham AL; Strbenac D; Robinson MD; Nair SS; Patterson KI; Tremethick DJ; Stirzaker C; Clark SJ
Genome Res; 2012 Feb; 22(2):307-21. PubMed ID: 21788347
[TBL] [Abstract][Full Text] [Related]
4. The histone variant H2A.Z is an important regulator of enhancer activity.
Brunelle M; Nordell Markovits A; Rodrigue S; Lupien M; Jacques PÉ; Gévry N
Nucleic Acids Res; 2015 Nov; 43(20):9742-56. PubMed ID: 26319018
[TBL] [Abstract][Full Text] [Related]
5. Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression.
Dryhurst D; McMullen B; Fazli L; Rennie PS; Ausió J
Cancer Lett; 2012 Feb; 315(1):38-47. PubMed ID: 22055461
[TBL] [Abstract][Full Text] [Related]
6. Patterning chromatin: form and function for H2A.Z variant nucleosomes.
Raisner RM; Madhani HD
Curr Opin Genet Dev; 2006 Apr; 16(2):119-24. PubMed ID: 16503125
[TBL] [Abstract][Full Text] [Related]
7. H2A.Z Represses Gene Expression by Modulating Promoter Nucleosome Structure and Enhancer Histone Modifications in Arabidopsis.
Dai X; Bai Y; Zhao L; Dou X; Liu Y; Wang L; Li Y; Li W; Hui Y; Huang X; Wang Z; Qin Y
Mol Plant; 2017 Oct; 10(10):1274-1292. PubMed ID: 28951178
[TBL] [Abstract][Full Text] [Related]
8. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
9. Analysis of active chromatin modifications in early mammalian embryos reveals uncoupling of H2A.Z acetylation and H3K36 trimethylation from embryonic genome activation.
Bošković A; Bender A; Gall L; Ziegler-Birling C; Beaujean N; Torres-Padilla ME
Epigenetics; 2012 Jul; 7(7):747-57. PubMed ID: 22647320
[TBL] [Abstract][Full Text] [Related]
10. Nucleosome stability mediated by histone variants H3.3 and H2A.Z.
Jin C; Felsenfeld G
Genes Dev; 2007 Jun; 21(12):1519-29. PubMed ID: 17575053
[TBL] [Abstract][Full Text] [Related]
11. Histone H2A.Z deregulation in prostate cancer. Cause or effect?
Dryhurst D; Ausió J
Cancer Metastasis Rev; 2014 Sep; 33(2-3):429-39. PubMed ID: 24398858
[TBL] [Abstract][Full Text] [Related]
12. A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.
Draker R; Ng MK; Sarcinella E; Ignatchenko V; Kislinger T; Cheung P
PLoS Genet; 2012; 8(11):e1003047. PubMed ID: 23144632
[TBL] [Abstract][Full Text] [Related]
13. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo.
Johnson TA; Chereji RV; Stavreva DA; Morris SA; Hager GL; Clark DJ
Nucleic Acids Res; 2018 Jan; 46(1):203-214. PubMed ID: 29126175
[TBL] [Abstract][Full Text] [Related]
14. Variant histone H2A.Z is globally localized to the promoters of inactive yeast genes and regulates nucleosome positioning.
Guillemette B; Bataille AR; Gévry N; Adam M; Blanchette M; Robert F; Gaudreau L
PLoS Biol; 2005 Dec; 3(12):e384. PubMed ID: 16248679
[TBL] [Abstract][Full Text] [Related]
15. H3.3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin.
Chen P; Zhao J; Wang Y; Wang M; Long H; Liang D; Huang L; Wen Z; Li W; Li X; Feng H; Zhao H; Zhu P; Li M; Wang QF; Li G
Genes Dev; 2013 Oct; 27(19):2109-24. PubMed ID: 24065740
[TBL] [Abstract][Full Text] [Related]
16. H2A histone-fold and DNA elements in nucleosome activate SWR1-mediated H2A.Z replacement in budding yeast.
Ranjan A; Wang F; Mizuguchi G; Wei D; Huang Y; Wu C
Elife; 2015 Jun; 4():e06845. PubMed ID: 26116819
[TBL] [Abstract][Full Text] [Related]
17. The histone variant H2A.Z interconverts two stable epigenetic chromatin states.
Zhao J; Siew WL; Sun W; Lehming N
Biochem J; 2011 Nov; 439(3):487-95. PubMed ID: 21736558
[TBL] [Abstract][Full Text] [Related]
18. A Read/Write Mechanism Connects p300 Bromodomain Function to H2A.Z Acetylation.
Colino-Sanguino Y; Cornett EM; Moulder D; Smith GC; Hrit J; Cordeiro-Spinetti E; Vaughan RM; Krajewski K; Rothbart SB; Clark SJ; Valdés-Mora F
iScience; 2019 Nov; 21():773-788. PubMed ID: 31727574
[TBL] [Abstract][Full Text] [Related]
19. H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression.
Dalvai M; Bellucci L; Fleury L; Lavigne AC; Moutahir F; Bystricky K
Oncogene; 2013 Sep; 32(36):4243-51. PubMed ID: 23108396
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles of H2A.Z in regulating promoter chromatin architecture in human cells.
Cole L; Kurscheid S; Nekrasov M; Domaschenz R; Vera DL; Dennis JH; Tremethick DJ
Nat Commun; 2021 May; 12(1):2524. PubMed ID: 33953180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
